Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere. The 2018/2019 edition of ICD-10-CM B96.81 became effective on October 1, 2018. This is the American ICD-10-CM version of B96.81 - other international versions of ICD-10 B96.81 may differ.
Helicobacter-associated gastritis ICD-10-CM K29.70 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 391 Esophagitis, gastroenteritis and miscellaneous digestive disorders with mcc 392 Esophagitis, gastroenteritis and miscellaneous digestive disorders without mcc
Campylobacter enteritis 2016 2017 2018 2019 2020 2021 Billable/Specific Code A04.5 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM A04.5 became effective on October 1, 2020.
Diagnosis Index entries containing back-references to A04.5: Diarrhea, diarrheal (disease) (infantile) (inflammatory) R19.7 ICD-10-CM Diagnosis Code R19.7 Enteritis (acute) (diarrheal) (hemorrhagic) (noninfective) K52.9 ICD-10-CM Diagnosis Code K52.9 Infection, infected, infective (opportunistic) B99.9 ICD-10-CM Diagnosis Code B99.9
ICD-10-CM Code for Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere B96. 81.
The note in ICD-10 under codes B95-B97 states that 'these categories are provided for use as supplementary or additional codes to identify the infectious agent(s) in disease classified elsewhere', so you would not use B96. 81 as a primary diagnosis, but as an additional code with the disease listed first.
C-13 or C-14 Breath Tests (78267, 78268, 83013, and 83014) should be billed as follows; Clinical Laboratory a. 83013 (C-13) should be billed for the analysis of the breath sample by mass spectrometry, and includes the drug/agent and kit/supplies.
In the revised version of ICD-10 (2003 ) Helicobacter pylori (HP) infection has been newly listed (B96. 8) as a cause of disease classified elsewhere.
2022 ICD-10-CM Diagnosis Code B96. 81: Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere.
These include 83013, “ Helicobacter pylori, breath test analysis (mass spectrometry)”; and 83014, “ Helicobacter pylori, breath test analysis (mass spectrometry); drug administration and sample collection” as well as 78267, “Urea breath test, C-14; acquisition for analysis,” and 78268, “Urea breath test, C-14; analysis ...
The serological test for H. pylori antigen (CPT code 87339) is not recommended. Screening services are not covered under Medicare. Procedure codes 83013 and 83014 should be used to describe the C-13 versions of the test, and 78267 and 78268 should be used to describe the C-14 versions of the breath tests.
pylori testing for any other etiology is not reasonable and necessary, and not a Medicare benefit.
BCBSNC will provide coverage for helicobacter pylori testing when it is determined to be medically necessary because the medical criteria and guidelines shown below are met.
H. pylori infection occurs when H. pylori bacteria infect your stomach. H. pylori bacteria are usually passed from person to person through direct contact with saliva, vomit or stool. H. pylori may also be spread through contaminated food or water.
pylori-caused ulcers are treated with a combination of antibiotics and an acid-reducing proton pump inhibitor. Antibiotics: Usually two antibiotics are prescribed. Among the common choices are amoxicillin, clarithromycin (Biaxin®), metronidazole (Flagyl®) and tetracycline.
Helicobacter pylori (H. pylori) is a type of bacteria that infects your stomach. It can damage the tissue in your stomach and the first part of your small intestine (the duodenum).
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code (s). The following references for the code B96.81 are found in the index:
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
Helicobacter pylori (H. pylori) is a type of bacteria that causes infection in the stomach. It is the main cause of peptic ulcers, and it can also cause gastritis and stomach cancer.
B96.81 is a valid billable ICD-10 diagnosis code for Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere . It is found in the 2022 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2021 - Sep 30, 2022 .
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically. See also:
To survive in the harsh, acidic environment of the stomach, H. pylori secretes an enzyme called urease, which converts the chemical urea to ammonia.The production of ammonia around H.pylori neutralizes the acidity of the stomach, making it more hospitable for the bacterium. In addition, the shape of H. pylori allows it to burrow into the mucus layer, which is less acidic than the lumen of the stomach. H. pylori can also attach to the cells that line the inner surface of the stomach.
H. pylori infection with the bacterium is common. The Centers for Disease Control and Prevention (CDC) estimates that approximately two-thirds of the world’s population harbors the bacterium, with infection rates much higher in developing countries than in developed nations.
Breath tests are not considered medically necessary for patients who are being screened for H. pylori infection in the absence of documented upper gastrointestinal tract symptoms and/or pathology, patients who have had upper gastrointestinal endoscopy within the preceding six weeks or for whom an upper gastrointestinal endoscopy is planned, patients who have non-specific dyspeptic symptoms with a negative H. Pylori serum antibody test, or patients who are asymptomatic after treatment of an H. pylori infection (either proven or suspected).
Serological testing for antibodies to H. pylori is inexpensive, convenient and simple, but, because antibody levels persist some months after treatment, it is not useful for assessing therapeutic effectiveness. Confirmation of successful H pylori cure may be necessary: In Patients with an H. pylori-associated ulcer.
Non-Invasive Specimen Collection (blood, breath, stool, etc) do not require endoscopy and are generally serological qualitative or semi-quantitative tests. The urea breath test or stool test is recommended for initial testing for H. pylori because they are non-invasive, accurate and cost-effective. Although the serological test for H. pylori antigen is non-invasive and cost-effective , it is not recommended for initial evaluation or for determination of eradication after treatment for H. pylori according to the American College of Gastroenterology.
The 2022 edition of ICD-10-CM Z86.19 became effective on October 1, 2021.
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status